NCT06783478View on ClinicalTrials.gov

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions
Acute Myeloid Leukaemia (AML)
Interventions
BIOLOGICAL

NK cell infusion

Six infusions of 1 x 10⁷/kg of haploidentical NK cells, in vitro expanded and activated.

OTHER

Placebo

Six infusions of placebo

Trial Locations (1)

90035903

Hospital de Clinicas de Porto Alegre, Porto Alegre

All Listed Sponsors
collaborator

Financiadora de Estudos e Projetos

OTHER

lead

Hospital de Clinicas de Porto Alegre

OTHER